NCT02551718 2022-06-30
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
University of Washington
Phase NA Completed
University of Washington
University of Washington
Virginia Commonwealth University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
Mayo Clinic
National Cancer Institute (NCI)